» Articles » PMID: 18786717

Atorvastatin Efficiency After Traumatic Brain Injury in Rats

Overview
Journal Surg Neurol
Specialty Neurosurgery
Date 2008 Sep 13
PMID 18786717
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The neuroprotective effects of statins possibly depend on their pleiotropic effect such as antioxidative and anti-inflammatory properties. In this study, we have evaluated the efficiency of atorvastatin on brain edema, lipid peroxidation, and ultrastructural changes in TBI animal model.

Methods: Modified Feeney method has been used for the trauma model in rats. Only craniectomy for group A and trauma after craniectomy for group B was the procedure for animals. For the trauma, rods weighing 24 g were dropped on a foot plate just over the dura. Atorvastatin (1 mg/kg, IP) was administered to the animals in group C after craniectomy and trauma; but on the other hand, animals in group D received only 0.5 mL PEG as the vehicle. Brains were harvested 24 hours after the trauma for the assays of wet-dry weight, lipid peroxidation level, and ultrastructural investigations. Lipid peroxidation levels, TEM, and UNGS were the investigated parameters. The statistical comparisons between the groups were investigated by 1-way ANOVA and post hoc analysis by Duncan and Dunnett T3 test within the groups at the significance level P = .05.

Results: Trauma increased water contents of the brain tissues and lipid peroxidation levels in groups B and D. When compared with the results of group B (brain edema, 84.694% +/- 1.510%; lipid peroxidation, 74.932 +/- 2.491 nmol/g tissue), atorvastatin (1 mg/kg) significantly decreased brain edema (77.362% +/- 1.448%), lipid peroxidation level (58.335 +/- 3.980 nmol/g tissue), and UNGS scores in group C (P < 0.05).

Conclusion: In this descriptive study, the remarkable improvements of atorvastatin on brain edema, lipid peroxidation, and ultrastructural investigations encouraged us for a further dose optimization study.

Citing Articles

The protective effects of statins in traumatic brain injury.

Pordel S, McCloskey A, Almahmeed W, Sahebkar A Pharmacol Rep. 2024; 76(2):235-250.

PMID: 38448729 DOI: 10.1007/s43440-024-00582-9.


Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side.

Jacquens A, Needham E, Zanier E, Degos V, Gressens P, Menon D Int J Mol Sci. 2022; 23(19).

PMID: 36232495 PMC: 9570205. DOI: 10.3390/ijms231911193.


Antioxidant therapies in traumatic brain injury.

Davis C, Vemuganti R Neurochem Int. 2021; 152:105255.

PMID: 34915062 PMC: 11884749. DOI: 10.1016/j.neuint.2021.105255.


The Effect of Oral Simvastatin on the Clinical Outcome of Patients with Severe Traumatic Brain Injury: A Randomized Clinical Trial.

Shafiee S, Zali A, Shafizad M, Emami Zeydi A, Ehteshami S, Rezaii F Ethiop J Health Sci. 2021; 31(4):807-816.

PMID: 34703180 PMC: 8512953. DOI: 10.4314/ejhs.v31i4.15.


Evaluation of the Effect of Atorvastatin Administration on the Outcomes of Patients with Traumatic Brain Injury: A Double-blinded Randomized Clinical Trial.

Soltani F, Janatmakan F, Jorairahmadi S, Javaherforooshzadeh F, Alizadeh P, Alipour I Anesth Pain Med. 2021; 11(4):e117140.

PMID: 34692441 PMC: 8520682. DOI: 10.5812/aapm.117140.